PTPavel P. Tereshkov

Pavel P. Tereshkov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Pavel P. Tereshkov has a total of 73 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Indicators of the innate immune system in patients with severe COVID-19 and their role in the development of coagulopathy

    by T. V. Gaydukova, T. O. Burdienko, E. V. Fefelova, P. P. Tereshkov, S. A. Lukyanov, N. N. Tsybikov

    SARS-CoV-2 is one of the few viruses that cause blood coagulation disorders. The pathogenesis of coagulopathies in COVID-19 is polyetiological: cytokine storm, NETosis, dysfunction of the renin-angiotensin system, thrombotic microangiopathy, disseminated intravascular coagulation (DIC), and hypofibrinolysis. However, the role of the immune system in the development of these disorders remains insufficiently described. The aim . To characterize the role of the innate immune system in the development of coagulopathies in patients with severe COVID-19. Methods . The study included a cohort of 103 patients with severe COVID-19 receiving anticoagulant therapy and undergoing treatment in Chita, Russia. Hemostasis was assessed using thrombodynamics testing, as well as measurement of fibrinogen, D-dimer, tissue plasminogen activator (tPA), and plasminogen activator inhibitor-1 (PAI-1). All patients with SARS-CoV-2 were stratified into four subgroups based on their hemostatic status. Levels of tissue factor (TF), D-dimer, tPA, PAI-1, myeloperoxidase (MPO), matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9), and cystatin C were determined by flow cytometry. Results . In the pronounced hypercoagulation and hypercoagulation groups, elevated fibrinogen levels were observed, along with a parallel increase in tPA concentration and a sharp rise in PAI-1 levels. Meanwhile, maximal TF-values were recorded in patients with hypocoagulation. MMP-2 levels were lower than those in the control group in all COVID-19 patients, but progressively increased from normocoagulation to hypocoagulation, reaching a maximum in the latter group. MMP-9 and MPO concentrations were elevated across all groups, peaking in the normocoagulation group. Cystatin C concentration was increased in all patients. Conclusion . Severe COVID-19 is associated with the development of thrombotic coagulopathy, driven by the formation of a vicious cycle of “thromboinflammation,” in which hemostatic disorders and systemic inflammatory response mutually reinforce each other.

  • Subpopulation and functional activity of regulatory T-lymphocytes in patients with chronic polyposis rhinosinusitis

    by T. M. Manikovskaya, E. V. Egorova, E. V. Fefelova, P. P. Tereshkov, N. N. Tsybikov

    Overcoming therapeutic resistance in chronic polypous rhinosinusitis (CRS) is directly linked to the recognition of its immunological heterogeneity. The modern paradigm views CRS as a spectrum of distinct endotypes (Th1, Th2, Th17), each requiring a specific targeted approach, making detailed immune profiling the cornerstone of personalized treatment strategies.    Objective.  To study the numerical composition and functional activity of T-regulatory lymphocytes at different stages of differentiation depending on the immune response type in patients with chronic polypous rhinosinusitis.    Materials and Methods.  The study included 44 patients suffering from chronic polypous rhinosinusitis. The control group consisted of 20 patients without chronic rhinosinusitis and concomitant pathology who underwent septoplasty. Using cluster analysis (k-means), all patients were divided into three clusters: 1 st – patients with T helper 1 type immune response, 2 nd – T helper 2 type, 3 rd – T helper 17 type immune response. The content of Treg cells with the CD4+CD25hiCD127low phenotype in the venous blood of the subjects and the levels of cytokines (IL-2, IL-6, IL-10, TGF-β1, TNF-α) in blood serum and tissue homogenates were studied using the multiplex analysis system "Human Essential Immune Response Panel" by Biolegend (USA).    Results. The total number of Treg was increased in Th-2 and Th-1 immune responses, while it was minimal in the Th-17 response. The pool of naive Treg was preserved only in the Th-2 immune response. A progressive decrease in memory Treg was observed from the Th-1/Th-2 to the Th-17 response. Systemic disturbances in cytokine balance have been identified, explaining various mechanisms of pathogenesis of nasal polyps formation with different types of immune response.    Conclusion.  Differences in the state of the immune regulatory system were established in patients with various immune endotypes of chronic polypous rhinosinusitis, manifested both at the level of cellular composition and the functional activity of T regulatory lymphocytes, which have a divergent nature depending on the CRS immune endotype. The concordance of changes in the cellular and cytokine profiles in peripheral blood and polyp tissue confirms the systemic nature of immunopathological disorders in CRS.

  • Cancer stem cells in colorectal cancer

    by V. V. Kryukova, V. L. Tsepelev, P. P. Tereshkov

    Background . Cancer stem cells (CSCs) are considered to be responsible for progression and recurrence of colorectal cancer (CRC). A detailed study of the phenotype of these cells and their immunobiological properties is necessary for developing CRC treatments. The aim of the study was to assess the percentage of EpCAM high /CD44 + cancer stem cells in colorectal cancer and to detect the expression of CD133, CD166, CD24 and CD184 on their surface. Material and Methods . A one-stage cross-sectional study of the cellular composition of tumor tissue was performed in 123 patients with stage III colon adenocarcinoma. The control group consisted of 87 patients who underwent surgery for non-neoplastic diseases of the colon. An enzymatic method was used to obtain a suspension of tumor tissue cells. Gating of non-lymphoid cells (CD45-) was performed depending on the expression of the epithelial cell adhesion molecule EpCAM and the differentiation antigen CD44 on their surface. Expression of EpCAM, CD44, CD133, CD166, CD184 and CD24 on CSCs was studied by fow cytometry. Results . The CD45-EpCAM high CD44+ colorectal cancer stem cells (CSCs) accounted for 17.15 % [11.76; 26.44] of the non-lymphoid cell population. Within this CSC population, 42.83 % [37.07; 51.77] simultaneously expressed CD133 and CD166, while 57.17 % [48.23; 62.93] expressed the CD133 antigen alone. All CSCs in the primary tumor expressed CD184, and 95.18 % [88.48; 97.98] of them simultaneously expressed CD24. The percentage of EpCAM high CD44 + cells in well-differentiated tumors was 1.5 times lower than that in moderately-differentiated tumors (U=326.5, p=0.002) and 2.1 times lower than in poorly-differentiated tumors (U=21.0, phigh CD44 + CD133 + CD166 + cells in stage IIIC CRC was 13 % higher than that in stage IIIB CRC (U=1116.0, p=0.007). Conclusion . In primary colorectal cancer tumors, cancer stem cells expressing high levels of EpCAM and CD44 accounted for 17.2 % of the non-lymphoid cell pool. The percentage of EpCAM high /CD44 + cells in poorly differentiated tumors was higher than that in well-or moderately-differentiated tumors.

  • Open Access

    Morphological and immunological features of chronic polypous rhinosinusitis depending on the presence of comorbid background

    by T. M. Manikovskaya, M. I. Serdtsev, T. B. Bayaskhalanova, P. P. Tereshkov, E. V. Fefelova, E. V. Egorova, N. N. Tsybikov

    Chronic rhinosinusitis is a heterogeneous and multifactorial inflammatory disease of the nasal mucosa and paranasal sinuses. Aim. To evaluate the morphological and some immunological features of nasal polyps in individuals suffering from chronic rhinosinusitis with various comorbid backgrounds. Materials and methods. The study included 76 patients with chronic polypous rhinosinusitis and comorbidities such as bronchial asthma(, hypertension, chronic obstructive pulmonary disease (COPD). The control group consisted of patients without chronic rhinosinusitis or associated comorbidities, operated on for septoplasty. We analyzed the quantitative and qualitative cellular composition of polyp biopsies and mucosal samples from the control group. The concentration of cytokines (IL- 8, IP-10, MCP-1) was determined in blood serum and tissue homogenates using the multiplex analysis system "Human Essential Immune Response Panel" by BioLegend (USA). Results. The total number of cells per 1 mm2 in polyp tissue was maximum in patients with a history of bronchial asthma and hypertension. In individuals with bronchial asthma, eosinophils and neutrophils prevailed in polyp preparations. In patients with hypertension and without comorbid conditions, lymphocytes prevailed. Biopsy specimens of nasal polyps in patients with COPD had approximately the same number of eosinophils and lymphocytes, with the maximum number of plasma cells. The concentration of IP-10 did not differ significantly in blood serum and tissue homogenate and was maximum in individuals with bronchial asthma. The maximum concentration of IL-8 was recorded in patients with bronchial asthma, and in tissues - in individuals with hypertension. The highest concentration of MCP-1 in both blood serum and polyp tissue homogenates was found in patients with bronchial asthma. Conclusions. The induction of polyp formation and their cellular composition are influenced by the patient’s comorbid background.

  • Regulatory T lymphocytes in regional lymph nodes of patients with colorectal cancer

    by Viktoriia V. Kriukova, Viktor L. Tsepelev, Pavel P. Tereshkov

    Objective: to identify changes in the regulatory T cell (Treg) pool and the expression level of inducible T-cell costimulator (ICOS) and programmed cell death protein (PD-1) on their membrane in metastatic lymph nodes in colorectal cancer (CC). Material and methods. The main group consisted of 105 patients with stage III CC. The clinical comparison group consisted of non-neoplastic pathology (developmental anomalies, stomas, diverticular disease of the colon). The Treg pool and the expression of PD-1 and ICOS were studied using flow cytometry. Results. In metastatic lymph nodes with RTC, the content of Treg increases by 3.5 times (p<0.001), the relative number of naive Treg decreases (p<0.001), the number of central memory Treg expressing CD197 on their membrane increases almost 2 times (p<0.001), and effector memory cells with the CD45RA–CD197– phenotype increase 3.6 times (p<0.001). The number of PD-1−ICOS+ Treg in the total population of CD3+ lymphocytes increases by 3.1 times (p<0.001). The number of Treg with the CD19−CD3+CD4+CD25highCD127−PD-1+ICOS+ phenotype increases by 1.5 times (p<0.001) compared to the control. Conclusion. In patients with RTC, the number of naive Treg in metastatically affected lymph nodes decreases, the relative content of central and effector memory Treg increases, the number of Treg expressing ICOS increases, as well as those simultaneously expressing both the inhibitory protein PD-1 and the stimulating molecule ICOS.

  • Open Access

    Regulatory T cells in the primary tumor growth lesion in colorectal cancer

    by V. V. Kryukova, V. L. Tsepelev, P. P. Tereshkov

    Introduction. Regulatory T cells (Treg) have pro-oncogenic activity, inhibit the immune response and therefore can be a significant target for immunotherapeutic methods of treating colorectal cancer (CRC). Currently, the role of regulatory T cells in the mechanisms of carcinogenesis, as well as the participation of co-inhibitory and co-stimulating proteins of the immune system in the formation of tumor immunosuppression in CRC, is insufficiently studied. Aim. To determine the content of Treg subtypes in the primary tumor focus in patients with CRC and to evaluate the expression level of co-stimulating and co-inhibitory proteins on their membrane. Materials and methods. The main group consisted of 105 patients with stage III colon adenocarcinoma; the control group – 75 patients with non-neoplastic diseases of the colon. The object of the study was tumor-infiltrating T lymphocytes, which were isolated by an enzymatic method. Determination of Treg subtypes, as well as expression of programmed cell death 1 (PD-1) and inducible T-cell costimulator (ICOS) proteins, was performed by flow cytometry. Treg was identified as CD19−CD3+CD4+CD25highCD127−. Based on the expression of CD45RA and CD197, Treg subtypes were determined as naive (CD45RA+CD197+), central memory (CD45RA–CD197+), effector memory (CD45RA–CD197–), and terminally differentiated (CD45RA+CD197–). The significance of differences in the parameters of the main and control groups was assessed using the nonparametric Mann–Whitney U test. Results. In the primary focus of tumor growth in CRC, the content of Treg increases by 4.4 times. At the same time, the ratio of Treg subtypes in the tumor microenvironment changes, which is expressed in a 1.4-fold decrease in the number of naive cells, as well as a 2.8-fold increase in the number of effector memory Treg and a 3.1-fold increase in terminally differentiated lymphocytes. Tumor-infiltrating Treg expressed the ICOS 2 times more strongly compared to the control. A 20 % increase in the number of Treg PD-1+ICOS+ was established. The number of Treg PD-1−ICOS− cells in the primary tumor focus decreased by 1.4 times compared to the control group. Conclusion. In patients with CRC, the number of naive Treg decreases in the primary tumor focus and the relative content of differentiated effector cells increases. In the tumor microenvironment in CRC, the number of Tregs increases, expressing on their surface both the costimulating molecule ICOS and the co-inhibitory receptor PD-1.


  • Open Access

    SERUM LEVEL OF SOLUBLE MOLECULES OF IMMUNE RESPONSE CHECKPOINTS IN PATIENTS WITH VARIOUS FORMS OF AUTOIMMUNE THYROIDITIS

    by V. V. Babinsky, Н. О. Гринь, P. P. Tereshkov, E. V. Fefelova, N. N. Tsybikov

    Introduction : The prevalence of chronic autoimmune thyroiditis (AIT) is more than 5% of the world's population. Despite this, the tactics and methods of treating AIT have not undergone innovations in terms of therapy for many years, while the modern trend in the treatment of other autopathologies is to use monoclonal antibodies. However, it was noted that with the use of some immune checkpoint inhibitors for the treatment of oncopathology, various autoimmune diseases debuted in patients. This fact opens up the prospect of studying new links in the pathogenesis of AIT. Aim : determination of the level of sCD25, s4-1BB, sTim-3, sLAG-3, sGalectin-9 molecules in individuals suffering from various forms of AIT. Material and methods : The study involved 31 subjects aged 18 to 40 years, divided into four groups: I Healthy (n = 10); II Carriers of antibodies to thyroid peroxidase (ATkTPO) (n = 11); III Subclinical form of hypothyroidism AIT (n = 6); IV AIT with hypothyroidism, medically compensated (n = 4). Venous blood was collected to determine the ATkTPO level by ELISA, the concentration of thyroid-stimulating hormone and free thyroxine by immunochemiluminescence, the level of CD25, 4-1BB, Tim-3, LAG-3, Galectin-9 by flow cytofluorimetry. Statistical processing was performed using the Kruskal-Wallis one-way analysis of variance. Results: The sCD25 level decreased by almost 85% (P = 0,001) from the control 19,2 pg/ml (2,20; 29,9) in groups: II 2.83 pg/ml (2,24; 3,17), III 3,23 pg/ml (2,69; 45,8), and IV 3,05 pg/ml (2,31; 7,37). The concentration of 4-1BB increased threefold (P = 0,001) in groups: II 35,0 pg/ml (15,5; 39,8), III 31,9 (27,8; 44,4) from the control 11,8 pg/ml (4,96; 14,0). sTim-3 decreased by more than 98% (P = 0,001) from group I 280 pg/ml (13,7; 321) when compared with groups: II 5,22 pg/ml (2,13; 6,34), III 4,10 pg/ml (3,36; 5,34), IV 1,26 pg/ml (0,362; 2,45). The content of LAG-3 decreased by 66% (P = 0,001) when comparing group, I 51,1 pg/ml (20,1; 60,1) with II 20,1 pg/ml (2,23; 41,6). The concentration of Galectin-9 in group II 277 pg/ml (196; 378) is 5 times lower than in I 1377 pg/ml (1140; 1910) (P = 0,001). Conclusion : With the development of AIT, the concentration of CD25, Tim-3, LAG-3, Galectin-9 decreases, and the level of 4-1BB increases.

  • Changes in the amount of matrix metalloproteinases and kynurenines in individuals with diabetic retinopathy, their role in the development of the disease

    by Olga A. Saklakova, Maria V. Maksimenya, Tatyana M. Karavaeva, Pavel P. Tereshkov, Anna A. Perelomova, Elena V. Fefelova, Максименя Мария Владимировна

    INTRODUCTION: Diabetic retinopathy (DR) is one of most common chronic complications of diabetes mellitus (DM). The pathogenesis of DR is complex and involves interaction of many molecular mechanisms, and far not all of them have been studied. AIM: To determine the level of matrix metalloproteinases and kynurenines in the blood of patients with type 2 DM (T2DM) with different stages of DR. MATERIALS AND METHODS: Four groups of patients were formed: Group 1 (control) — 21 healthy individuals; Group 2 — 21 patients with prediabetes, Group 3 — 21 patients with T2DM, Group 4 — 63 patients with T2DM and DR. Then patients with DR were divided into groups (n = 21): Group 5 — non-proliferative stage of DR, Group 6 — preproliferative DR, Group 7 — proliferative DR. In the blood serum, the following parameters were determined: the content of metalloproteinases (MMP) types 2 and 9 (MMP-2, MMP-9) by the enzyme immunoassay; in blood plasma — the concentration of kynurenines by the high-performance liquid chromatography. RESULTS: Significant differences were recorded in the studied parameters between healthy individuals and patients with diabetes. Subsequently, the results of patients with different stages of DR were compared with the data of patients with diabetes without vascular complications. In the preproliferative stage of DR, an excess of blood MMP-2 by 87.9% (p = 0.030) and MMP-9 by 37% (p = 0.049) was recorded relative to the individuals with diabetes. In the proliferative stage of DR, the levels of MMP-9 and MMP-2 were higher than those of not only the comparison group, but also the groups of non-proliferative and preproliferative stages of DR. In the preproliferative stage of DR, an increased concentration of 3-hydroxykynurenine was also recorded. The maximum increase in kynurenines was noted in the final stage of DR (p 0.05 relative to the groups of non-proliferative and preproliferative DR). CONCLUSIONS: In the analyzed groups of individuals, the concentrations of kynurenines increased as the underlying disease progressed. The level of MMP-9 was higher in diabetes mellitus, and in the proliferative stage of DR, the values of MMP-9 and MMP-2 increased.

  • Open Access

    Cytotoxic T lymphocytes in regional lymph nodes in colon cancer

    by V. V. Kryukova, V. L. Tsepelev, P. P. Tereshkov

    Background. The study of the subpopulation composition of cytotoxic T lymphocytes and the expression of co-inhibitory proteins on their surface in regional lymph nodes is necessary for the development of new methods of targeted therapy for colorectal cancer (CRC). The aim. To assess the subpopulation composition of cytotoxic T lymphocytes and the expression of co-inhibitory molecules on their surface in regional lymph nodes in patients with colon cancer. Methods. The relative content of cytotoxic T lymphocytes in regional lymph nodes, the subpopulation composition of cytotoxic T lymphocytes, and the expression of immune checkpoints (CTLA-4, PD-1, TIM-3) by CD8-positive cells in 105 patients with stage III colorectal cancer were determined using flow cytometry. The control group consisted of 75 patients who underwent colon surgery for non-neoplastic diseases. Results. In patients with CRC, the number of naive CD8+ lymphocytes (CD3+CD8+CD45RA+CCR7+) in regional lymph nodes decreases by 1.6 times, the relative content of cytotoxic T lymphocytes of effector memory (CD3+CD8+CD45RA-ССR7-) increases by 2.6 times, and the relative content of CD8-positive cells expressing CD57 on their surface increases by 2.6 times. In patients with CRC, on the surface of CD3+CD8+ lymphocytes of regional lymph nodes, the expression of the co-inhibitory molecule CTLA-4 increases by 4.5 times, PD-1 by 2.2 times, and TIM-3 protein by 1.7 times. Conclusion. In patients with colorectal cancer, the subpopulation composition of cytotoxic T lymphocytes in regional lymph nodes changes, which is expressed in a decrease in the proportion of naive cells and an increase in the relative content of effector memory cells. In CRC, the expression of co-inhibitory molecules (CTLA-4, PD-1 and TIM-3) on cytotoxic T lymphocytes in regional lymph nodes increases.

  • Open Access

    The Effect of Antipsychotic Therapy on the Dynamics of the Chemokines CXC Subfamily Indices in Blood of First Episode Schizophrenia Patients

    by A. V. Sakharov, A. S. Prokhorov, S. E. Golygina, P. P. Tereshkov

    Background: neuroinflammation as a universal mechanism of development of endogenous mental disorders, including schizophrenia, is given close attention. Chemokines claim to be markers of the neuroinflammation process within the framework of schizophrenia. Antipsychotics can affect the content of certain cytokines, but similar studies on chemokines are rare. The aim was to investigate the indicators of chemokines of the CXC subfamily in blood of patients with a first episode of schizophrenia, including indices dynamics during therapy with haloperidol and risperidone. Patients, control groups and methods: 80 patients aged 18 to 35 years with the diagnosis F20.09 («Paranoid schizophrenia, observation period less than a year»), in whom the indices of chemokines of the CXC subfamily: CXCL1 (GRO-α), CXCL5 (ENA-78), CXCL8 (IL-8), CXCL9 (MIG), CXCL10 (IP-10), CXCL11 (I-TAC) were studied in blood plasma by flow fluorimetry before and after 8 weeks of therapy with haloperidol (n = 40) or risperidone (n = 40). The control group was 35 healthy volunteers. Results: patients with schizophrenia onset had elevated levels of IL-8 and GRO-α and decreased levels of ENA-78, MIG, and I-TAC before therapy. When haloperidol was administered for 8 weeks, a significant increase in IL-8 and I-TAC was recorded. This was not observed with risperidone therapy. An increase in plasma concentrations of GRO-α, ENA-78, a tendency to a continued decrease in MIG, as well as a high rate of IL-8 are registered in first episode schizophrenia patients after 8 weeks of treatment regardless of the antipsychotic taken. Conclusion: abnormalities in the plasma content of a number of chemokines of the CXC subfamily are initially present in patients with a first episode of schizophrenia, indicating their possible involvement in the mechanisms of this disorder. Antipsychotics have a multidirectional effect on the dynamics of chemokine values in blood, which requires further research.